JASON MATUNAS: Open Payments
NPI 1205542727 · LAKEWOOD RANCH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,671 in 53 payments from 16 companies in 2025. Trend: 2023 $1,366 · 2024 $1,896 · 2025 $1,671
Food & beverage: $1,671
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $287 |
| Ardelyx, Inc. | 9 | $240 |
| Aimmune Therapeutics, Inc. | 10 | $220 |
| PFIZER INC. | 9 | $148 |
| Gilead Sciences, Inc. | 2 | $148 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| GENZYME CORPORATION | 3 | $123 |
| Regeneron Healthcare Solutions, Inc. | 4 | $87 |
| Ipsen Biopharmaceuticals, Inc | 3 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $48 |
Products named: REZDIFFRA, IBSRELA, DUPIXENT, VOQUEZNA, Livdelzi, ZENPEP, VOWST, IQIRVO.
Industry payments across FL — which companies pay providers there.
